Chlormidazole
Small moleculeexperimental
Chlormidazole is used as a spasmolytic and azole antifungal drug. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2019 (NCT04619914)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1nc2ccccc2n1Cc1ccc(Cl)cc1- Mol. weight
- 256.74 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaChlormidazole ↗
- ChEMBLCHEMBL152649 ↗
Also known as
- chlormidazole
- chlormidazole
- chlormidazole
- chlormidazole
- chlormidazole
- clomidazole
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04600284 | Phase 1 | Nov 30, 2020 | Addpharma Inc., Korea University |
| NCT04619914 | N/A | Mar 1, 2019 | Zagazig University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Addpharma Inc. | For profit | 1 | 1 | 1 | 2020 |
| Korea University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Zagazig University | Academic/Hospital | 1 | 1 | 1 | 2019 |
3 organizations
Page 1 / 1